These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34033123)

  • 1. Recurrence, postponing pregnancy, and termination rates after hyperemesis gravidarum: Follow up of the MOTHER study.
    Nijsten K; Dean C; van der Minnen LM; Bais JMJ; Ris-Stalpers C; van Eekelen R; Bremer HA; van der Ham DP; Heidema WM; Huisjes A; Kleiverda G; Kuppens SM; van Laar JOEH; Langenveld J; van der Made F; Papatsonis D; Pelinck MJ; Pernet PJ; van Rheenen-Flach L; Rijnders RJ; Scheepers HCJ; Vogelvang T; Mol BW; Roseboom TJ; Koot MH; Grooten IJ; Painter RC
    Acta Obstet Gynecol Scand; 2021 Sep; 100(9):1636-1643. PubMed ID: 34033123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital admission for hyperemesis gravidarum: a nationwide study of occurrence, reoccurrence and risk factors among 8.2 million pregnancies.
    Fiaschi L; Nelson-Piercy C; Tata LJ
    Hum Reprod; 2016 Aug; 31(8):1675-84. PubMed ID: 27251205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis.
    Boelig RC; Barton SJ; Saccone G; Kelly AJ; Edwards SJ; Berghella V
    J Matern Fetal Neonatal Med; 2018 Sep; 31(18):2492-2505. PubMed ID: 28614956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence patterns of hyperemesis gravidarum.
    Nurmi M; Rautava P; Gissler M; Vahlberg T; Polo-Kantola P
    Am J Obstet Gynecol; 2018 Nov; 219(5):469.e1-469.e10. PubMed ID: 30121224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence risk of hyperemesis gravidarum.
    Fejzo MS; Macgibbon KW; Romero R; Goodwin TM; Mullin PM
    J Midwifery Womens Health; 2011; 56(2):132-6. PubMed ID: 21429077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperemesis gravidarum and pregnancy outcomes in the Norwegian Mother and Child Cohort - a cohort study.
    Vikanes ÅV; Støer NC; Magnus P; Grjibovski AM
    BMC Pregnancy Childbirth; 2013 Sep; 13():169. PubMed ID: 24004605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leisure-time physical activity before pregnancy and risk of hyperemesis gravidarum: a population-based cohort study.
    Owe KM; Støer N; Wold BH; Magnus MC; Nystad W; Vikanes ÅV
    Prev Med; 2019 Aug; 125():49-54. PubMed ID: 31077724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early nasogastric tube feeding in optimising treatment for hyperemesis gravidarum: the MOTHER randomised controlled trial (Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding).
    Grooten IJ; Mol BW; van der Post JAM; Ris-Stalpers C; Kok M; Bais JMJ; Bax CJ; Duvekot JJ; Bremer HA; Porath MM; Heidema WM; Bloemenkamp KWM; Scheepers HCJ; Franssen MTM; Oudijk MA; Roseboom TJ; Painter RC
    BMC Pregnancy Childbirth; 2016 Jan; 16():22. PubMed ID: 26819104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norwegian PUQE (Pregnancy-Unique Quantification of Emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: a prospective cohort validation study.
    Birkeland E; Stokke G; Tangvik RJ; Torkildsen EA; Boateng J; Wollen AL; Albrechtsen S; Flaatten H; Trovik J
    PLoS One; 2015; 10(4):e0119962. PubMed ID: 25830549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early enteral tube feeding in optimizing treatment of hyperemesis gravidarum: the Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding (MOTHER) randomized controlled trial.
    Grooten IJ; Koot MH; van der Post JA; Bais JM; Ris-Stalpers C; Naaktgeboren C; Bremer HA; van der Ham DP; Heidema WM; Huisjes A; Kleiverda G; Kuppens S; van Laar JO; Langenveld J; van der Made F; van Pampus MG; Papatsonis D; Pelinck MJ; Pernet PJ; van Rheenen L; Rijnders RJ; Scheepers HC; Vogelvang TE; Mol BW; Roseboom TJ; Painter RC
    Am J Clin Nutr; 2017 Sep; 106(3):812-820. PubMed ID: 28793989
    [No Abstract]   [Full Text] [Related]  

  • 11. Women's perspectives on the management and consequences of hyperemesis gravidarum - a descriptive interview study.
    Havnen GC; Truong MB; Do MH; Heitmann K; Holst L; Nordeng H
    Scand J Prim Health Care; 2019 Mar; 37(1):30-40. PubMed ID: 30822254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of disease course and severity in hyperemesis gravidarum.
    Koot MH; Grooten IJ; van der Post JAM; Bais JMJ; Ris-Stalpers C; Leeflang MMG; Bremer HA; van der Ham DP; Heidema WM; Huisjes A; Kleiverda G; Kuppens SM; van Laar JOEH; Langenveld J; van der Made F; van Pampus MG; Papatsonis D; Pelinck MJ; Pernet PJ; van Rheenen-Flach L; Rijnders RJ; Scheepers HCJ; Vogelvang TE; Mol BW; Roseboom TJ; Painter RC
    Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():162-167. PubMed ID: 31923736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. History of depression and risk of hyperemesis gravidarum: a population-based cohort study.
    Kjeldgaard HK; Eberhard-Gran M; Benth JŠ; Nordeng H; Vikanes ÅV
    Arch Womens Ment Health; 2017 Jun; 20(3):397-404. PubMed ID: 28064341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperemesis gravidarum].
    Koot MH; Grooten IJ; Gauw NE; Roseboom TJ; Painter RC
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperemesis gravidarum and the risk of emotional distress during and after pregnancy.
    Kjeldgaard HK; Eberhard-Gran M; Benth JŠ; Vikanes ÅV
    Arch Womens Ment Health; 2017 Dec; 20(6):747-756. PubMed ID: 28842762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proportion of hyperemesis gravidarum and associated factors among pregnant women admitted into the obstetrics ward at Akesta general hospital, North East Ethiopia.
    Adane KD; Zerga AA; Gebeyehu FB; Ayele FY
    PLoS One; 2023; 18(2):e0281433. PubMed ID: 36745599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management of nausea and vomiting in pregnancy and hyperemesis gravidarum across primary and secondary care: a population-based study.
    Fiaschi L; Nelson-Piercy C; Deb S; King R; Tata LJ
    BJOG; 2019 Sep; 126(10):1201-1211. PubMed ID: 30786126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal vomiting during early pregnancy and cardiovascular risk factors at school age: the Generation R Study.
    Poeran-Bahadoer S; Jaddoe VWV; Gishti O; Grooten IJ; Franco OH; Hofman A; Steegers EAP; Gaillard R
    J Dev Orig Health Dis; 2020 Apr; 11(2):118-126. PubMed ID: 31474237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid-stimulating hormone and free thyroxine fail to predict the severity and clinical course of hyperemesis gravidarum: A prospective cohort study.
    Nijsten K; Koot MH; van der Post JAM; Bais JMJ; Ris-Stalpers C; Naaktgeboren C; Bremer HA; van der Ham DP; Heidema WM; Huisjes A; Kleiverda G; Kuppens SM; van Laar JOEH; Langenveld J; van der Made F; Papatsonis D; Pelinck MJ; Pernet PJ; van Rheenen-Flach L; Rijnders RJ; Scheepers HCJ; Siegelaar SE; Vogelvang T; Mol BW; Roseboom TJ; Grooten IJ; Painter RC
    Acta Obstet Gynecol Scand; 2021 Aug; 100(8):1419-1429. PubMed ID: 33606270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of hyperemesis gravidarum: A national register-based study in Finland, 2005-2017.
    Nurmi M; Rautava P; Gissler M; Vahlberg T; Polo-Kantola P
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1003-1013. PubMed ID: 32030718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.